| 000 | 03603nam a22003974u 4500 | ||
|---|---|---|---|
| 001 | 10.1002/9781394175482 | ||
| 003 | Wiley | ||
| 005 | 20251030120317.0 | ||
| 007 | cr nn 008mam|a | ||
| 008 | 240314t2024||||xxu fs| |0|| 0|eng|| | ||
| 020 |
_a9781394175482 _qelectronic |
||
| 024 | 7 |
_a10.1002/9781394175482 _2doi |
|
| 041 | _aeng | ||
| 245 | 0 | 0 |
_aNanocarrier Vaccines _bBiopharmaceuticsâBased Fast Track Development _h[electronic resource] _cEdited by Vivek P. Chavda, Vasso Apostolopoulos. |
| 250 | _a1 | ||
| 260 |
_bWiley _c2024 |
||
| 264 | 1 |
_bWiley _c2024 |
|
| 300 | _a528pp.; | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _2rdaft |
||
| 347 | _bPDF | ||
| 520 | _aNANOCARRIER VACCINES This book details the benefits, restrictions, and types of nanoparticles used in the creation of vaccines for the treatment and prevention of illnesses. In nanomedicine and nano-delivery systems, materials in the nanoscale range are used as diagnostic instruments or to administer therapeutic compounds to particular targeted regions in a controlled manner. By delivering precise medications to specified locations and targets, nanotechnology provides several advantages in treating chronic human illnesses. The use of nanomedicine (including chemotherapeutic medicines, biological agents, immunotherapeutic agents, etc.) in the treatment of various diseases has recently seen many notable applications. This book aims to be a single source material for understanding all the current and novel advancements in the field of nanotechnology. In this groundbreaking book the reader will find: biodegradable and non-biodegradable formulations and properties such as size, shape, charge, inertness, efficacy, morphology, and more; show how different nanoparticles, such as lipid-based, viral vector-based, and metal, uphold very significant properties individually, suggesting applicability in various management tactics; examines how genetic information-carrying entities are becoming the norm for eradicating some diseases; gathers an exhaustive amount of information on routes of administration such as the oral route, mucosal immunity, intramuscular, subcutaneous, and intradermal; explores the legal regulations for nanotechnology-based approaches. Audience Researchers and pharmacy students in biomedical engineering and chemical engineering, biotechnology, as well as pharmaceutical and biopharmaceutical industry engineers working in drug discovery, chemical biology, computational chemistry, medicinal chemistry, and bioinformatics. | ||
| 650 | 4 |
_aPharmaceutical & Medicinal Chemistry _991083 |
|
| 650 | 4 |
_aNanobiotechnology _967632 |
|
| 650 | 4 |
_aClinical Pharmacology & Therapeutics _991176 |
|
| 653 | 0 | 0 | _aVaccines; nanoparticles; immunogenicity; data science; Process Development; Pharmaceuticals; Biopharmaceuticals; Pharma; Nano-Vaccines; Biocompatibility; liposome formulations; Fast-track development; Future Perspectives; Biocompatibility; Antigen Presenting Cells |
| 700 | 1 |
_aChavda, Vivek P. _4edt _992065 |
|
| 700 | 1 |
_aApostolopoulos, Vasso _4edt _992066 |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9781394174683 |
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/9781394175482 _aWiley Online Library |
| 856 | 4 | 0 |
_uhttps://onlinelibrary.wiley.com/action/showBook?doi=10.1002%2F9781394175482 _aWiley Online Library |
| 856 | 4 | 2 |
_3Cover Image _uhttps://onlinelibrary.wiley.com/cms/asset/2b93530f-31fa-401c-86bc-8739bc8f4808/9781394175482.cover.gif _aWiley Online Library |
| 999 |
_c67203 _d67203 |
||